Press releases

BETHESDA, MD and DUBLIN, Ireland – May 19, 2014 – Covidien, a global health care technology and medical supplies provider, and the National Association of Community Health Centers (NACHC)...

MINNEAPOLIS - May 19, 2014 - Medtronic, Inc. (NYSE: MDT) announced the appointment of Brad Lerman as senior vice president, general counsel and corporate secretary effective May 27, 2014. In this...

TEMPE, ARIZ. - May 14, 2014 - The Medtronic Tempe Campus, a manufacturing site for the world's leading medical technology company, has been named 2014 Manufacturer of the Year by the Arizona...

MINNEAPOLIS - May 13, 2014 - Medtronic, Inc. (NYSE: MDT) today announced the selection of Hooman Hakami as executive vice president and group president of the Medtronic Diabetes Group, the global...

MINNEAPOLIS - May 13, 2014 - Medtronic, Inc. (NYSE: MDT) announced today it will report financial results for the fourth quarter and fiscal year 2014 on Tuesday, May 20, 2014. A news release will...

MINNEAPOLIS - May 1, 2014 - Medtronic today announced that 10 students have been selected as 2014 Medtronic Wallin Scholars. Each will receive a four-year scholarship totaling $16,000, as well as...

MINNEAPOLIS and SAN FRANCISCO - May 10, 2014 - Medtronic, Inc. (NYSE: MDT) today announced the results from the first prospective randomized clinical trial to show that Medtronic implantable...

MINNEAPOLIS and SAN FRANCISCO - May 10, 2014 - New data presented as a late-breaking clinical trial at the Heart Rhythm Society's 2014 Annual Scientific Sessions show that an advanced pacing...

HeartWare International, Inc. (NASDAQ:HTWR), a leading innovator of less invasive, miniaturized circulatory support technologies that are revolutionizing the treatment of advanced heart failure,...

MINNEAPOLIS and SAN FRANCISCO - May 9, 2014 - Medtronic, Inc. (NYSE: MDT) today released study findings that show heart failure patients who have limited options for implanted device therapy may...

MINNEAPOLIS - May 9, 2014 - Medtronic (NYSE: MDT) will host an institutional investor and analyst meeting on Thursday, June 5, 2014, in New York City from 8:30 a.m. to approximately 1:00 p.m....

ISTANBUL--(BUSINESS WIRE)--May 7, 2014-- Further expanding its training and research capabilities in emerging markets, Covidien plc (NYSE: COV), has officially opened its Covidien Center of Innovation

MINNEAPOLIS - MAY 6, 2014 - Medtronic, Inc. (NYSE: MDT) today announced that it has agreed with certain plaintiffs' counsel to settle their inventories of filed and unfiled product liability...

DUBLIN, Ireland--(BUSINESS WIRE)--May 6, 2014-- Covidien plc (NYSE: COV) will present at the Bank of America Merrill Lynch 2014 Health Care Conference in Las Vegas on May 14. Bryan Hanson, group...

MINNEAPOLIS - March 31, 2014 - Medtronic, Inc. (NYSE: MDT) today announced the final follow-up results from the CoreValve® CE Pivotal Study, which demonstrated excellent long-term durability at...

HeartWare International, Inc. (Nasdaq: HTWR), today issued a voluntary Urgent Medical Device Correction related to all HeartWare® Ventricular Assist System batteries, product codes 1650 and...

HeartWare International, Inc. (NASDAQ: HTWR), a leading innovator of less invasive, miniaturized circulatory support technologies that are revolutionizing the treatment of advanced heart failure,...

MINNEAPOLIS, MAY 1, 2014 - Medtronic, Inc. (NYSE:MDT) today announced CE (Conformité Européenne) Mark receipt and the European launch of its newest cardiac resynchronization therapy-pacemaker,...

DUBLIN, Ireland--(BUSINESS WIRE)--May 1, 2014-- Covidien plc (NYSE: COV) will present at the Deutsche Bank 39th Annual Health Care Conference in Boston on May 8. Charles J. Dockendorff, executive...

MINNEAPOLIS - April 29, 2014 -Medtronic, Inc. (NYSE: MDT) today announced five-year follow-up data demonstrating the safety and performance of the Medtronic 3f Enable® Aortic Bioprosthesis - the...

TORONTO and MINNEAPOLIS - April 29, 2014 - Medtronic, Inc. (NYSE: MDT) today revealed new data demonstrating positive outcomes for extreme risk patients with severe aortic stenosis who were...

MINNEAPOLIS - April 28, 2014 - Medtronic has been recognized as a top U.S. corporate citizen by Corporate Responsibility Magazine. The publication's 100 Best Corporate Citizens List, released this...

DUBLIN, Ireland--(BUSINESS WIRE)--Apr. 25, 2014-- Covidien plc (NYSE: COV) today announced financial results for the second quarter of fiscal 2014. Second-quarter net sales of $2.60 billion...

HeartWare International, Inc. (NASDAQ:HTWR) has scheduled a conference call to discuss its financial results for the three months ended March 31, 2014, at 8:00 a.m. U.S. Eastern Daylight Time on...

MINNEAPOLIS - April 22, 2014 -Medtronic today announced the first U.S. implant of the Evera MRI(TM) SureScan® implantable cardioverter-defibrillator (ICD) System, following U.S. Food and Drug...

MINNEAPOLIS - April 21, 2014 - The Federal Circuit Court of Appeals today granted a request from Medtronic, Inc. (NYSE: MDT) to postpone the implementation of an injunction that would have...

MINNEAPOLIS - April 21, 2014 - Medtronic, Inc. (NYSE: MDT) today issued an updated statement on the recent ruling by Federal District Court of Delaware. The ruling granted in part Edwards...

MINNEAPOLIS -- April 18, 2014 -- The Endurant AAA stent graft system from Medtronic, Inc. (NYSE: MDT) continues to demonstrate exceptional long-term performance in the endovascular treatment of...

DUBLIN, Ireland--(BUSINESS WIRE)--Apr. 14, 2014-- Covidien plc (NYSE: COV) today announced U.S. Food and Drug Administration 510(k) Clearance for the Kangaroo™ feeding tube with IRIS Technology....

MINNEAPOLIS - April 11, 2014 - The Federal District Court of Delaware today granted in part Edwards Lifesciences' motion for a preliminary injunction that prevents Medtronic, Inc. (NYSE: MDT) from...

DUBLIN, Ireland--(BUSINESS WIRE)--Apr. 11, 2014-- Covidien plc today announced that it has notified customers of a voluntary recall to address an issue with certain lots of its Pipeline™...

MINNEAPOLIS - April 10, 2014 - Medtronic, Inc. (NYSE: MDT) today announced that the U.S. Food and Drug Administration (FDA) approved an expanded indication for biventricular (BiV) pacing with...

MINNEAPOLIS - April 10, 2016 - This weekend, an article was published in the Minneapolis Star Tribune that criticized Medtronic's handling of data collected during a retrospective chart review...

MINNEAPOLIS - April 9, 2014 - Medtronic today announced CE (Conformité Européenne) Mark and European launch of the Evera MRI(TM) SureScan® implantable cardioverter-defibrillator (ICD) System,...

ISTANBUL - April 7, 2014 - Medtronic, Inc. today announced that one of its subsidiaries has acquired a majority of the shares of Biostar, which will assume the distribution of Medtronic products...

LONDON -- April 5, 2014 --Patients with peripheral artery disease in the upper leg experienced significantly better outcomes at 12 months after treatment with the IN.PACT Admiral drug-coated...

MINNEAPOLIS - March 31, 2014 - Medtronic, Inc. (NYSE: MDT) today announced the final follow-up results from the CoreValve® CE Pivotal Study, which demonstrated excellent long-term durability at...

MINNEAPOLIS - March 6, 2014 - Medtronic, Inc. (NYSE: MDT) today announced that the European Patent Office (EPO) has invalidated, in its entirety, the Edwards Lifesciences EP2055266 Spenser patent...

MINNEAPOLIS and WASHINGTON, D.C. - March 30, 2014 - Medtronic, Inc. (NYSE: MDT), announced today further analysis of six-month follow-up data from the first 1,000 patients enrolled in the Global...

MINNEAPOLIS and WASHINGTON - March 30, 2014 - Medtronic, Inc. (NYSE: MDT), today announced the one-year results of the Melody® Transcatheter Pulmonary Valve (TPV) U.S. Post-Approval Study, which...

MINNEAPOLIS and WASHINGTON - March 29, 2014 - Medtronic, Inc. (NYSE: MDT) today announced that the CoreValve® System showed results superior to surgical aortic valve replacement (SAVR) at one...

MINNEAPOLIS and WASHINGTON, DC - March 29, 2014 - Medtronic, Inc. (NYSE: MDT) today announced the full results of the SYMPLICITY HTN-3 clinical trial, which were presented today in late-breaking...

DENVER, Colo. and DUBLIN, Ireland – March 28, 2014 – In a move aimed at giving nursing professionals the tools they need to address rapidly changing practices and cost structures, the AORN...

Minneapolis - March 27, 2014 -Medtronic, Inc. (NYSE:MDT) today announced the first patients were enrolled in the Improve SCA Clinical Study, a first-of-its-kind study that will identify patients...

DUBLIN--(BUSINESS WIRE)--Mar. 25, 2014-- An innovative Covidien (NYSE: COV) technology is effective at treating Barrett’s esophagus (a precancerous condition of the esophagus), according to a...

DUBLIN, Ireland--(BUSINESS WIRE)--Mar. 19, 2014-- Covidien plc (NYSE:COV) today announced that its Board of Directors has declared a quarterly cash dividend of $0.32 per ordinary share. The...

DUBLIN, Ireland--(BUSINESS WIRE)--Mar. 19, 2014-- Covidien plc (NYSE: COV) announced the results from today’s Annual General Meeting. Seven proposals were on the meeting agenda: Election of...

DUBLIN, Ireland--(BUSINESS WIRE)--Mar. 14, 2014-- Covidien plc (NYSE: COV) will report second-quarter fiscal 2014 results on April 25. The company will host a conference call for investors at 8:30...

DUBLIN, Ireland--(BUSINESS WIRE)--Mar. 13, 2014-- Further strengthening its broad line of hernia repair products, Covidien plc (NYSE: COV) today announced the U.S. launch of Symbotex™ composite...

MINNEAPOLIS - March 10, 2014 - Medtronic, Inc. (NYSE: MDT) announced today applications are open to runners around the world who benefit from medical technology to represent their country on the...

HeartWare International, Inc. (NASDAQ:HTWR), a leading innovator of less invasive, miniaturized circulatory support technologies that are revolutionizing the treatment of advanced heart failure,...

DUBLIN, Ireland--(BUSINESS WIRE)--Mar. 6, 2014-- Covidien plc (NYSE: COV) will present at the Barclays Global Healthcare Conference 2014 in Miami on March 13. Charles J. Dockendorff, executive...

DUBLIN, Ireland--(BUSINESS WIRE)--Mar. 3, 2014-- Covidien plc (NYSE: COV), a leading global provider of healthcare products and recognized innovator in patient monitoring and respiratory care...

HARTFORD, Conn. and MINNEAPOLIS, March 3, 2014 - Beginning this month, Aetna (NYSE: AET) and Medtronic, Inc. (NYSE: MDT) will work with doctors in a new program to reach up to 300 fully insured...

MINNEAPOLIS - Mar 6, 2014 - Medtronic, Inc. (NYSE: MDT), the world's leading medical technology company, today announced it will participate in the Barclays Global Healthcare Conference on...

DUBLIN, Ireland--(BUSINESS WIRE)--Feb. 27, 2014-- Covidien plc (NYSE: COV) today announced that it has closed its acquisition of Given Imaging Ltd., providing the company additional scale and...

HeartWare International, Inc. (NASDAQ: HTWR), a leading innovator of less invasive, miniaturized circulatory support technologies that are revolutionizing the treatment of advanced heart failure,...

MINNEAPOLIS - Feb 27, 2014 - Medtronic, Inc. (NYSE: MDT), the world's leading medical technology company, today announced it will participate in the Cowen and Company 34th Annual Healthcare...

HeartWare International, Inc. (NASDAQ: HTWR), a leading innovator of less invasive, miniaturized circulatory support technologies that are revolutionizing the treatment of advanced heart failure,...

DUBLIN, Ireland--(BUSINESS WIRE)--Feb. 26, 2014-- Covidien plc (NYSE: COV), a leading global provider of healthcare products and recognized innovator in patient monitoring and respiratory care...

DUBLIN, Ireland--(BUSINESS WIRE)--Feb. 24, 2014-- Covidien plc (NYSE: COV) will present at the Raymond James 35th Annual Institutional Investors Conference in Orlando, Fla., on March 3. Charles J....

MINNEAPOLIS -- February 21, 2014 -- On February 20, 2014, Medtronic, Inc. (NYSE: MDT) registered an offering of $250 million principal amount of its 0.875% Senior Notes due 2017, $250 million...

MINNEAPOLIS - Feb. 20, 2014 - Continuing its leadership in advanced pacing technology and device miniaturization, Medtronic, Inc. (NYSE: MDT), today announced the first U.S. implant of the world's...

MINNEAPOLIS - February 19, 2014 -Medtronic, Inc. (NYSE: MDT) today announced U.S. Food and Drug Administration (FDA) 510(k) clearance, CE (Conformité Européenne) Mark, and the global launch of...

MINNEAPOLIS - Feb. 18, 2014 - Medtronic, Inc. (NYSE: MDT) today announced financial results for its third quarter of fiscal year 2014, which ended January 24, 2014. The company reported worldwide...

DUBLIN, Ireland--(BUSINESS WIRE)--Feb. 18, 2014-- Covidien plc (NYSE: COV) will present at two upcoming investor conferences -- the Citi 2014 Global Healthcare Conference on Feb. 25 and the RBC...

MINNEAPOLIS - Feb 18, 2014 - Medtronic, Inc. (NYSE: MDT), the world's leading medical technology company, today announced it will participate in the 2014 Citi Global Healthcare Conference on...

(Thomson Reuters ONE via COMTEX) --MINNEAPOLIS - February 14, 2014 - Medtronic, Inc. (NYSE: MDT), today announced results from the CRYSTAL AF (CRYptogenic STroke And underLying Atrial...

MINNEAPOLIS -- Feb. 13, 2014 -- Aligned with its commitment to provide innovative medical technology for the interventional treatment of peripheral artery disease, Medtronic, Inc. (NYSE: MDT) has...

MINNEAPOLIS - February 13, 2014 - Medtronic, Inc. (NYSE:MDT) has begun distribution of i-port Advance® as part of a continued focus to provide meaningful therapy management solutions for people...

MINNEAPOLIS - February 13, 2014 - The board of directors of Medtronic, Inc. (NYSE:MDT) today approved a cash dividend of $0.28 per share of the Company's common stock. The quarterly dividend...

MINNEAPOLIS - Feb. 11, 2014 - Medtronic, Inc. (NYSE: MDT) announced today it will report financial results for the third quarter of its fiscal year 2014 on Tuesday, February 18, 2014. A news...

(Thomson Reuters ONE via COMTEX) --Latest Continuous Glucose Monitoring Sensor Provides Improved Comfort and Sensing Experience VIENNA - February 6, 2014 - Medtronic, Inc. (NYSE:MDT) today...

DUBLIN, Ireland--(BUSINESS WIRE)--Feb. 6, 2014-- Covidien plc. (NYSE:COV) announced that the U.S. Food and Drug Administration has granted 510(k) clearance for the company’s Endo GIA™...

DUBLIN, Ireland--(BUSINESS WIRE)--Feb. 4, 2014-- Covidien plc (NYSE: COV) will present at the 2014 Leerink Global Healthcare Conference in New York on Feb. 12. Coleman N. Lannum, vice president,...

HeartWare International, Inc. (NASDAQ:HTWR), a leading innovator of less invasive, miniaturized circulatory support technologies that are revolutionizing the treatment of advanced heart failure,...

HeartWare International, Inc. (NASDAQ:HTWR) has scheduled a conference call to discuss its financial results for the three months ended December 31, 2013, at 8:00 a.m. U.S. Eastern Standard Time...

Dubai, UAE - 28 January 2014, Medtronic, Inc. (NYSE: MDT), the world's largest medical technology company, providing therapies to treat many conditions including cardiac and vascular diseases,...

MINNEAPOLIS -- Jan. 28, 2014 -- Continuing to expand the role of endovascular aortic repair, Medtronic, Inc. (NYSE: MDT) has received approval from the U.S. Food and Drug Administration (FDA) for...

DUBLIN, Ireland--(BUSINESS WIRE)--Jan. 27, 2014-- Covidien plc (NYSE: COV) today announced that Charles J. Dockendorff, executive vice president and chief financial officer, has decided to retire...

DUBLIN, Ireland--(BUSINESS WIRE)--Jan. 27, 2014-- Covidien plc (NYSE: COV) today announced that its Japanese subsidiary, Covidien Japan Inc., has received Shonin approval from the Japanese...

DUBLIN, Ireland--(BUSINESS WIRE)--Jan. 24, 2014-- Covidien plc (NYSE: COV) today announced financial results for the first quarter of fiscal 2014 (October - December 2013). First-quarter net sales of

MUMBAI, India--(BUSINESS WIRE)--Jan. 23, 2014-- Further developing its capabilities in a key emerging market, Covidien (NYSE:COV) has officially opened its first training and education center in...

DUBLIN, Ireland--(BUSINESS WIRE)--Jan. 23, 2014-- Covidien plc. (NYSE: COV) does not infringe certain patents held by Ethicon Endo-Surgery, Inc., a Johnson & Johnson company, according to a...

BOULDER, Colo.--(BUSINESS WIRE)--Jan. 22, 2014-- Expanding its industry-leading vessel and tissue sealing portfolio, Covidien (NYSE:COV) received U.S. Food and Drug Administration (FDA) 510(k)...

MINNEAPOLIS - January 22, 2014 - Medtronic, Inc. (NYSE: MDT), today announced that the Medtronic SureScan® pacing systems - the first and only pacing systems in the United States that have been...

MINNEAPOLIS - Jan. 22, 2014 - Medtronic, Inc. (NYSE: MDT) announced that the U.S. Supreme Court ruled 9-0 in favor of Medtronic that the burden of proving infringement rests with the party...

DUBLIN, Ireland--(BUSINESS WIRE)--Jan. 21, 2014-- Covidien plc (NYSE: COV) today announced it will exit its OneShot™ Renal Denervation program. This voluntary action is primarily in response to...

MINNEAPOLIS - Jan. 17, 2014 - Medtronic, Inc. (NYSE: MDT) today announced the U.S. Food and Drug Administration (FDA) approval of the self-expanding transcatheter CoreValve® System for severe...

DUBLIN, Ireland--(BUSINESS WIRE)--Jan. 16, 2014-- Covidien plc (NYSE: COV) today announced that its Board of Directors has declared a quarterly cash dividend of $0.32 per ordinary share. The...

MINNEAPOLIS - Jan. 15, 2014 - A jury in the Federal District Court of Delaware today decided in favor of Edwards Lifesciences, ruling that the Medtronic (NYSE:MDT) CoreValve® System infringed on...

DUBLIN--(BUSINESS WIRE)--Jan. 15, 2014-- Covidien plc (NYSE: COV) today announced that it has completed the sale of its Confluent Surgical product line to Integra LifeSciences Corporation for...

HeartWare International, Inc. (NASDAQ: HTWR), a leading innovator of less invasive, miniaturized circulatory support technologies that are revolutionizing the treatment of advanced heart failure,...

DUBLIN, Ireland--(BUSINESS WIRE)--Jan. 13, 2014-- Moving decisively to accelerate a key component of its emerging markets strategy, Covidien plc (NYSE:COV) has completed two transactions – one...

MINNEAPOLIS - January 9, 2014 - Medtronic, Inc. (NYSE: MDT) today announced that its U.S. pivotal trial in renal denervation for treatment-resistant hypertension, SYMPLICITY HTN-3, failed to meet...

DUBLIN, Ireland--(BUSINESS WIRE)--Jan. 9, 2014-- Covidien plc (NYSE: COV), Lightstone Ventures and New Enterprise Associates (NEA) will jointly invest in a new company launched by The Foundry, a...

MINNEAPOLIS - Jan 6, 2014 - Medtronic, Inc. (NYSE: MDT), the world's leading medical technology company, today announced it will participate in the 32nd annual J.P. Morgan Healthcare Conference on...

MINNEAPOLIS - Jan. 6, 2014 - Medtronic, Inc. (NYSE:MDT) today announced the first patient has been enrolled in the VICTORY AF clinical trial, a prospective, non-randomized, controlled study of...

MINNEAPOLIS - Jan. 06, 2014 - Medtronic, Inc. (NYSE: MDT) today announced that it has acquired TYRX, Inc., a privately held, New Jersey-based developer of implantable combination antibiotic drug...

Thomson Reuters ONE via COMTEX) --Medtronic's Second Randomized, Controlled Renal Denervation Clinical Trial in the U.S. Will Potentially Expand Access to the Symplicity(TM) Renal Denervation...